We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » London Court Invalidates Pfizer’s Pain Patent for Lyrica
London Court Invalidates Pfizer’s Pain Patent for Lyrica
The UK Court of Appeal affirmed an earlier ruling that invalidated Pfizer’s patent claims for Lyrica and ruled generics would not lead to infringements.
